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'Mitochondrial energy imbalance and lipid peroxidation
cause cell death in Friedreich’s ataxia'
R Abeti1,5, MH Parkinson1, IP Hargreaves2, PR Angelova3, C Sandi4,6, MA Pook4, P Giunti*,1,7 and AY Abramov3,7
Friedreich’s ataxia (FRDA) is an inherited neurodegenerative disease. The mutation consists of a GAA repeat expansion within the
FXN gene, which downregulates frataxin, leading to abnormal mitochondrial iron accumulation, which may in turn cause changes
in mitochondrial function. Although, many studies of FRDA patients and mouse models have been conducted in the past two
decades, the role of frataxin in mitochondrial pathophysiology remains elusive. Are the mitochondrial abnormalities only a side
effect of the increased accumulation of reactive iron, generating oxidative stress? Or does the progressive lack of iron-sulphur
clusters (ISCs), induced by reduced frataxin, cause an inhibition of the electron transport chain complexes (CI, II and III) leading to
reactive oxygen species escaping from oxidative phosphorylation reactions? To answer these crucial questions, we have
characterised the mitochondrial pathophysiology of a group of disease-relevant and readily accessible neurons, cerebellar granule
cells, from a validated FRDA mouse model. By using live cell imaging and biochemical techniques we were able to demonstrate
that mitochondria are deregulated in neurons from the YG8R FRDA mouse model, causing a decrease in mitochondrial membrane
potential (ΔΨm) due to an inhibition of Complex I, which is partially compensated by an overactivation of Complex II. This complex
activity imbalance leads to ROS generation in both mitochondrial matrix and cytosol, which results in glutathione depletion and
increased lipid peroxidation. Preventing this increase in lipid peroxidation, in neurons, protects against in cell death. This work
describes the pathophysiological properties of the mitochondria in neurons from a FRDA mouse model and shows that lipid
peroxidation could be an important target for novel therapeutic strategies in FRDA, which still lacks a cure.
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Friedreich’s ataxia (FRDA) is an autosomal recessively
inherited neurodegenerative disorder, characterised by pro-
gressive spinocerebellar ataxia, together with cardiomyopa-
thy, scoliosis and diabetes.1,2 FRDA is caused by a
homozygous GAA repeat expansion mutation within intron 1
of the FXN gene.3 Unaffected individuals have 5–30 GAA
repeats, whereas affected individuals have 70 to more than
1000 GAA triplets. The GAA expansion mutation reduces the
expression of frataxin, a ubiquitous mitochondrial protein that
is involved in iron-sulphur cluster (ISC) and haem
biosynthesis.4 Evidence suggests that frataxin deficiency
inhibits mitochondrial respiration and promotes production of
reactive oxygen species (ROS), causing mitochondrial dys-
function, oxidative stress and subsequent mitochondrial iron
accumulation.4,5 These effects result in neuronal atrophy,
where the primary sites of pathology are the dorsal root
ganglia,6 and the dentate nucleus of the cerebellum.7 Previous
studies of mitochondrial pathophysiology have been per-
formed on post-mortem tissues or fibroblasts. However,
mitochondria can be affected by the procedures of tissue
extraction and conservation making these studies unreliable,
whereas fibroblasts are not affected in FRDA and so
pathological changes in these cells may not reflect underlying
disease processes. The Fxn knockout mouse model has been
shown to be embryonic lethal, and this has been followed by
the development of conditional knockout mouse models
specific for the central nervous system or the heart.8 Although
useful for understanding some features of frataxin, these
models could not be studied for one of the main features of the
FRDA condition, which is the slow progression.8 We used a
humanisedmousemodel, the YG8R transgenicmousemodel,
which contains a human FXN YAC with 190+90 GAA repeats
on a mouse Fxn null background, that recapitulates the
progressive disease phenotype shown in humans.9–12 A
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similar approach has generated a control transgenic mouse
that contains the same human FXN YAC, but with only nine
GAA repeats, called Y47R mice.13 These mouse models
have been validated and extensively used in studies on
FRDA.9,14,15 Althoughmitochondrial dysfunction is believed to
be one of the main causes of FRDA pathology, the effect of
frataxin deficiency on mitochondrial function is not yet clear.
The present study sought to investigate the changes in
mitochondrial physiology in FRDA-like cerebellar granule
neurons and glia, by using hemizygous YG8R mice (with a
defective FXN transgene) and hemizygous Y47R mice (with a
normal FXN transgene). The cerebellum is one of the most
affected tissues in FRDA pathology7,16–18 and cerebellar
granule neurons have previously been shown to be lost in an
inducible Fxn knockout FRDA mouse model.19 Although,
patients show clear sings of cerebellar ataxia, it is not clear
where the pathophysiology lies amongst the cerebellar
neurons. In this work we aimed to investigate whether
cerebellar granule neurons and glial cells, which are largely
unexplored in FRDA, could be affected by the presence of the
GAA repeat expansion and to investigate how frataxin
deficiency could affect neuronal cell viability.
Results
YG8R cerebellar granule and glial cells show reduced
frataxin levels. Frataxin levels were measured in co-cultures
of cerebellar granule neurons and glial cells from Y47R and
YG8R mice. Using immunofluorescence, we labelled human
frataxin and measured the fluorescence intensity cell-by-cell,
differentiating granule cells from glia with a neuronal marker
(anti-MAP-2) (Figure 1A). We found that there is a significant
decrease of frataxin in both cerebellar granule neurons and
glial cells in the YG8R genotype, when compared to the
Y47R (Figure 1B; granule cells YG8R 11.1%± 1.3, n= 97
cells; Figure 1C; glia YG8R 15.9± 1.2, n= 95 cells;
**Po0.01; n= 3 independent experiments).
The YG8R mouse model shows a molecular phenotype not
earlier than 4 months of age and this is progressive as mice
become older.14 Our experiments on primary cultures of
neurons and glia show that the level of frataxin is representa-
tive of an adult phenotype of the mouse model. Indeed, when
we measured the level of frataxin in the cerebellum of 8.5-
month-old mice, we found that the level of frataxin is
significantly decreased compared with the control (Y47R).
The western blot image in Figure 1D shows a visible decrease
in hFXN in YG8R cerebella compared with Y47R mice of the
same age. The quantification of three independent experi-
ments is represented in the histogram (Figure 1E; Y47R
1.12±0.24, YG8R 0.59± 0.17; three independent experi-
ments in duplicates of n=3 mice; ***P= 0.0004), normalising
the hFXN signal with a mitochondrial marker, the apoptotis-
inducing factor protein (AIF).
Since it is known that frataxin is involved in the biosynthesis
of haem and acts as a chaperon for ISCs,20,21 its activity is
crucial for those proteins that require ISCs to perform
their functional activity,22 such as Complexes I and III
of the mitochondrial electron transport chain (ETC) and
aconitase.14,22 As Complexes I and III are fundamental for
the maintenance of the mitochondrial membrane potential
(ΔΨm), we investigated if mitochondrial respiration could be
dependent on frataxin activity and therefore be affected by the
decrease of this protein.
YG8R cerebellar granule cells exhibit ΔΨm abnormal-
ities. ΔΨm is a unique indicator of mitochondrial health. By
using tetramethylrhodamine (TMRM) fluorescence, we inves-
tigated whether cells expressing reduced frataxin could
reveal differences in ΔΨm. The basal level of ΔΨm in YG8R
cerebellar granule neurons was significantly lower than Y47R
cells (Figure 2a YG8R granule cells 72.01%±1.3, n=100
cells; **Po0.005), suggesting a crucial role of frataxin in ΔΨm
maintenance. Although the level of frataxin in YG8R glia cells
is also very low (15.9% of the control), the ΔΨm in these cells
was similar for the two genotypes (Figure 2b; glia YG8R
98.03%±1.403, n=106 cells). This suggests a specific role
of frataxin on mitochondria in granule cells or the presence of
compensatory mechanisms in glia cells which maintain ΔΨm
in conditions of low frataxin. The ΔΨm is normally generated
by the respiratory chain. However, when this is compromised,
the hydrolysis of ATP by the F1F0-ATPase (Complex V) will
occur, pumping protons out of the mitochondria and thus
maintaining the ΔΨm.23 To understand and explore the basis
of the decrease of ΔΨm in granule cells in our FRDA model,
we examined the changes in ΔΨm in response to specific
mitochondrial inhibitors. The application of oligomycin (2 μg/
ml), the F1F0-ATPase inhibitor, induced no changes or small
hyperpolarisation in Y47R granule compared with YG8R
(Figure 2c and d). Importantly, in YG8R granule cells, the
addition of oligomycin induced a slow and sustained
decrease in ΔΨm (Figure 2d). Consecutive addition of
Complex I inhibitor, rotenone (5 μM) induced, as expected,
a profound mitochondrial depolarisation in all the cells, with
complete depolarisation in YG8R granule cells (Figure 2d).
These results suggest that in YG8R granule cells the ΔΨm is
mainly maintained by respiration. Addition of substrates for
Complex I (5 mM pyruvate and 5 mM malate) 12 h prior to
recording, induced a slight increase of the ΔΨm in granule
cells (Figure 2e). These results show that by giving Complex I
substrate the loss of ΔΨm in response to oligomycin can be
rescued in YG8R granule cells, suggesting that the level of
mitochondrial substrates could be the limiting factor for the
respiratory chain in YG8R granule cells. In glial cells from
YG8R cultures, the basal level of ΔΨm was similar to Y47R;
however, we examined ΔΨm maintenance using the same
experimental protocol as for granule cells. Investigating the
ΔΨm in glial cells, we found that the YG8R cells were
responding as control (Figure 2f) corroborating the results
looking at the basal level of ΔΨm, thus confirms that glial cells
do not seem to be affected by the decreased level of frataxin,
at least not in a bioenergetic manner as they can switch to
glycolysis to sustain respiration.24
Levels of NADH and FAD in granule cells from YG8R
mice. Considering the difference in the level ΔΨm of neurons
and glia, we used a method that measures activity of
mitochondrial respiration in single cells and tissue slices.
The activity of the respiration in single cell or tissue slices can
be estimated by measuring the autofluorescence of the major
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substrate for Complex I—NADH and FAD— to estimate the
Complex II activity.
We found that the NADH pool in granule cells of YG8R is
significantly lower than Y47R (Figure 3c; Y47R 47.69±0.045;
YG8R 21.96±0.04; **Po0.005; and n= 100 cells per
genotype), which could be due to a lack of substrates for
Complex I, that is in agreement with the ability of substrates to
recover the ΔΨm in these cells (Figure 2a). The NADH redox
index (the balance between production of NADH in the
tricarboxylic acid cycle (TCA) and oxidation in Complex I)
was not significantly different between the two genotypes in
granule cells from primary cultures (Figure 3d; Y47R
87.42±0.05; YG8R 79.35±0.053; n= 100 cells per geno-
type). The NADH pool measured in acute slices, as opposed
to single cells, did not show a significant decrease in YG8R in
granule cells (Figure 3e; Y47R 100± .0.035; YG8R 95±0.04;
n=3 mice per genotype). This suggests that in a more
complicated and perhaps more physiological system, such
as cerebellar slices, there is a form of compensatory
effect from other components of the ETC. The NADH redox
state was also unaltered in granule cells (Figure 3f; Y47R
26.1± 0.048; YG8R 30±0.05; n= 3 independent experi-
ments) from acute slices isolated from aged (8.5 months)
animals.
We then looked at Complex II activity in primary cultures and
acute slices measuring FAD autofluorescence cerebellar
granule cells. Interestingly, the FAD pool and FAD redox state
in granule cells from primary cultures (Figure 4a–c) were
similar between the two genotypes (Y47R 47.02± 0.03 of
YG8R 51.35± 0.026), indicating that Complex II was not
compromised. By using the acute slices from aged mice we
found that the FAD pool was significantly lower, reflecting an
Figure 1 Decrease of FXN in granule cells and glia from YG8R mice. (A) The panel on the left shows immunofluorescence on co-cultures of granule cells and glia in the two
genotypes: Y47R (control), YG8R (190 and 90 GAA repeats; FRDA model). In a and c are shown the merge of DAPI (blue), α-MAP-2 (green) and α-FXN (red), while b and d
show α-hFXN (red). (B, C) The histograms represent the mean intensity of the α-hFXN antibody measured cell-by-cell. On top the histogram shows the mean of hFXN level in
granule cells and on the bottom in glial cells. The fluorescence was averaged between cells and number of animals used (three independent experiments were conducted per
case). In both cell types granule cells and glia, the level of FXN is significantly decreased in YG8R cells (**Po0.01; one–way ANOVA test with Bonferroni correction), compared
with Y47R. (D) The figure shows the western blot on α-hFXN and α-AIF conducted on cerebella extracts of 8.5-months-old mice. (E) The histogram shows the quantification of the
western blot (three independent experiments and n= 3 mice; ***P= 0.0004; t-test)
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overactivation of the Complex II (Figure 4d; Y47R 100±0.052
of YG8R 79.8±0.046; *Po0.05; n=3mice per genotype) and
the FAD redox state was significantly higher in granule cells
from FRDA-like mice (Figure 4e; Y47R 38.90± 0.04 and
YG8R 79.8± 0.033; n=3 mice per genotype; **Po0.005).
Mitochondrial respiration complex activities in YG8R
cerebella. To further investigate mitochondrial function in our
models, we studied the effect of the YG8R genotype on
oxygen consumption in isolated mitochondria from cerebella.
The basal rate of respiration (V2) of YG8R mitochondria in
the medium containing substrates for Complex I (5 mM
glutamate/5 mM malate) was slower than control values
(Figure 5a and b; compare 1.6±0.01 in Y47R to 0.86±0.012
in YG8R, n=3 mice). The maximal rate of respiration can be
stimulated by uncoupler FCCP (0.5 μM). We have found that
the maximal rate of respiration in glutamate/malate medium
was significantly less in YG8R (compare 1.9±0.017 to
3.4± 0.14 in control, n=3; **Po0.005; Figure 5c). Impor-
tantly, the respiratory control ratio (the ratio between ADP
dependent (V3) and ADP independent respiration) was
similar for both genotypes in glutamate/malate (Y47R
1.5± 0.037; YG8R 1.32± 0.04; Figure 5b). Experiments
conducted in the medium with substrate for Complex II
(5 mM succinate plus inhibitor of Complex I 5μM rotenone)
produced results that were directly opposite, that is, an
increase of the maximal rate in FRDA-like cerebella (Fig. 5c;
5.3± 0.08 in YG8R compared with control 3.5± 0.07; n=3;
**Po0.005). The respiratory control ratio, in the presence of
succinate and rotenone, was similar for both genotypes
Figure 2 Study of Δψm in YG8R granule cells and glia. (a and b) The histograms represent the mean of the peak intensity value of TMRM (25 nM), taken cell-by-cell, and
averaged between cells and number of animals used (no. of cells= 150 per case). Although cerebellar granule neurons show a difference between Y47R (control) and YG8R
(**Po0.005; one–way ANOVA test with Bonferroni correction), on the left side of the histogram (a), astrocytes do not seem to be affected by the presence of the mutated gene in
YG8R (b). This is because of the fact that granule and glial cells have a different energy metabolism. (c and d) The graph shows the differential response to oligomycin (an
inhibitor of Complex V of the ETC) from granule Y47R and granule YG8R; where YG8R cells show a decrease of potential during oligomycin, meaning that these cells cannot
maintain their Δψm (no. of cells= 100 per case). (e) The curve shows the response to oligomycin in granule YG8R cells treated with Complex I substrates (5 mM pyruvate and
5 mM malate for 12 h). (f) The curve shows the mean of responses from glial cells to oligomycin, from YG8R (f). In glial cells, YG8R show a normal response on regards toΔψm
maintenance (no. of cells= 140 per case)
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(Y47R 1.17±0.1; YG8R 1.12± 0.12; Figure 5d) suggesting
the absence of mitochondrial uncoupling in YG8R mito-
chondria. These results strongly suggest the inhibition of
Complex I in YG8R mitochondria with compensatory activa-
tion of Complex II.
Therefore, we further investigated the activity of the ETC
Complexes (CI, CII–III and CIV) in cerebellar homogenates
(Figure 6a–c). Data were normalised by total protein concen-
tration and citrate synthase activity was used as a mitochon-
drial activity marker. In YG8Rmice, CI activity was significantly
lower than in Y47R mice (Figure 6a; Y47R 0.013±0.003;
YG8R 0.005±0.0009; n=8mice; *P=0.02). As suggested by
our previous experiments the level of CII–III activities in YG8R
mice was not significantly different compared with Y47R mice
(Figure 6b; Y47R 0.003±0.0008; YG8R 0.002± 0.0005; n= 8
mice), confirming that CII is not impaired. Interestingly, CIV
activity in YG8R mice was significantly lower than Y47R mice
(Figure 6c; Y47R 0.0008± 0.0002; YG8R 0.0004±5.1e− 05;
n= 8 mice; **P= 0.008). In the case of Complex IV inhibition
molecular oxygen coming from Complex III cannot be
converted into H2O and that could also increases ROS.
Mild mitochondrial impairment causes generation of
ROS. Partial and complete inhibition of the Complex I can
result in excessive ROS production, which may be a reason
for cell death.25–27 Figure 7 shows an increase of mROS
measured with mitosox in Y47R and YG8R. The rate of
mROS is significantly higher in YG8R granule cells (Figure 7a
and b; Y47R 0.48± 0.01; YG8R 0.27± 0.02; *Po0.05; n= 3
independent experiments). We also found that cytosolic ROS
was increased in YG8R granule cells (Figure 7c and d; Y47R
0.03± 0.016; YG8R 0.27±0.08; **Po0.05; n=3 indepen-
dent experiments). If ROS are not counteracted by scaven-
gers and antioxidants, the excessive ROS generation can
result in oxidative stress that leads to oxidation of lipids. To
investigate the effect of decreased frataxin on the level of the
major neuronal antioxidant glutathione, we used a specific
probe, monochlorobimine. We found that excessive ROS
Figure 3 Investigation of NADH autofluorescence in cerebellar granule cells in culture and acute cerebellar slices. (a and b) The application of mitochondrial uncoupler 1 μM
FCCP maximises the rate of respiration and oxidises the mitochondrial NADH pool in cells, resulting in a decrease of detected fluorescence (minimum= 0% for NADH; 3A; 3B).
The subsequent application of the Complex IV inhibitor, 1 mM NaCN, suppresses respiration preventing NADH oxidation and allowing the NADH pool to be regenerated
(maximum= 100% for NADH; 3A; 3B) The first trace shows the response to 1 μM FCCP and 1 mM NaCN in a mean of granule cells Y47R, the second shows YG8R. (c). The
histogram represents the NADH pool calculated from the traces above in both genotypes (**P= 0.0057; Mann–Whitney test). (d) Shows the NADH redox level in granule cells.
(e and f) Show respectively the NADH pool and the redox state in % in granule cells from acute slices, where no significant differences were found when comparing YG8R to Y47R
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generation from the mitochondria and the cytosol of YG8R
cerebellar granule cells led to a significantly decreased
level of reduced glutathione (GSH) compared with controls
(Figure 7e; Y47R 112± 20.9; YG8R 76±11.5; ***Po0.0005;
n= 3 independent experiments). To estimate the rate of lipid
peroxidation in the Y47R and YG8R cells, we used the
indicator C11-BODIPY (581/591). We found that the rate of
lipid peroxidation in YG8R cells was 10.6-fold higher than
Y47R cells (Figure 8a and b; YG8R 10.6± 0.02; **Po0.005;
n= 3 independent experiments). The dramatic increase of
lipid peroxidation suggests that this may be a crucial effect of
frataxin silencing. To confirm that the lipid peroxidation has a
central role in frataxin-deficient cells, we have challenged
cells with a novel compound that counteracts lipid peroxida-
tion and looked at cell death.
Cell death in granule cells from YG8R mice. Since lipid
peroxidation was most severely increased (10-fold) in YG8R
granule cells, we assessed cell death with and without the
presence of a compound called d4-PUFA, which has been
shown to counteract the oxidation of lipids in vitro.28 By
measuring cell death in granule cell cultures with propidium
iodide (PI), we assessed the level of death in untreated cells
compared with cells treated with 100 μM d4-PUFA (24 h
incubation). Figure 8c shows that the compound remarkably
prevented YG8R cell death (YG8R 21.9±0.34; d4-PUFA-
YG8R 1.75±0.52; and n=3 independent experiments).
Interestingly, Y47R cells do not show the physiological basal
level of cell death, demonstrating that d4-PUFA is also
beneficial in control cultures. This result suggests that the
mild bioenergetic impairments lead to an increase of ROS
that immediately generate peroxidation of lipids in the vicinity
of PUFA-rich mitochondrial membrane and throughout the
cell.29,30
Discussion
Although the role of frataxin is largely known, being funda-
mental for the iron biogenesis in the cell, the relation between
frataxin and mitochondrial bioenergetics is not completely
clear. Here, we demonstrate the close participation of frataxin
in maintaining healthy mitochondrial physiology of cerebellar
granule neurons. For the first time, using a validated FRDA
model, we have investigated mitochondrial physiology with
functional microscopy techniques. We found that, the frataxin-
deficient YG8R mouse model showed a limitation of the
maintenance of ΔΨm in cerebellar granule neurons, with a
specific deficiency in Complex I. Complex I substrates, such
as pyruvate and malate, incubated for 12 h, prevent the ΔΨm
maintenance defects observed in YG8R cerebellar granule
cells. The NADH pool in primary cultures of granule cells is
significantly decreased in YG8R cultures, even if the
NAD+/NADH redox state is not significantly different to the
control. The dramatic decrease ofΔΨm seems to be caused by
Figure 4 Investigation of FAD autofluorescence in cerebellar granule cells and acute cerebellar slices. (a) The application of mitochondrial uncoupler 1 μM FCCP maximises
the rate of respiration and oxidises the mitochondrial FADH2 pool in cells, resulting in an increase of detected fluorescence (maximum= 100% for FAD; 4A). The subsequent
application of the Complex IV inhibitor, 1 mM NaCN, suppresses respiration decreasing the level of FAD (minimum=−0% for FAD; 4A). The first trace shows the response to
1 μM FCCP and 1 mM NaCN in a mean of primary cultures of cerebellar granule cells form Y47R looking at FAD autofluorescence. (b and c) The histograms represent the FAD
pool calculated from the trace above in both genotypes in granule cells and the level of FAD redox state. No significant differences were detected between genotypes from primary
cultures. (d and e) Show respectively the FAD pool and the redox state in granule cells from acute slices which were both significantly different, between Y47R and YG8R
(*Po0.05 and **Po0.005)
Energy imbalance and lipid peroxidation in FRDA
R Abeti et al
6
Cell Death and Disease
a lack of NADH availability for Complex I to work. This could be
due to a normal consumption of NADH by the TCA cycle,
which cannot be regenerated by new NAD+ reduction due to
other proteins usage. One of the possible candidates could be
PARP-1, which uses NAD+ during severe oxidative stress31
and could affect the action of sirtuin proteins.32 The crucial
function of sirtuins has been revealed due to their inactivation
in FRDA models,33 causing massive hyperacetylation and
genomic instability.34 This inactivation is linked to NAD+
deprivation (as a limiting factor of sirtuin activities) and
excess of nicotinamide, which are both effects of PARP-1
overactivity.32 This should be the object to future investiga-
tions. By looking at acute cerebellar slices, the level of NADH
does not seem to be particularly affected in cerebellar granule
neurons. However, the redox state of FAD is significantly
increased, demonstrating that Complex II is overworking.
These results were also confirmed with two other different
techniques: firstly by measuring oxygen consumption in
isolated mitochondria, and secondly by measuring Complex
activities. The first technique showed that while the maximal
respiration for Complex I decreases, Complex II is increased.
This explainswhy respiratory control does not seem to change
between the two genotypes. It also indicates that Complex I
has a mild impairment and that Complex II is slightly
overworking to compensate the respiration. Indeed the
respiratory control is not significantly defective. By investigat-
ing the Complex activities we confirmed that Complex I is less
active and that Complexes II–III are not affected. Complex IV
also demonstrated compromised activity, indicating that the
increase of ROS may also be due to an impairment of this
Complex. The inhibition of Complex IV was found in FRDA
patient’s lymphoblasts and that could perhaps not only be
induced by a lower activity of the Complex III but also from a
deficiency present in Complex IV due to lower frataxin and the
haem chain impairments.35
Inhibition of Complex I with activation of Complex II can
stimulate the reverse flux of electrons and the production of
ROS on both sides of the mitochondrial membrane.36 Here we
have demonstrated that the levels of mitochondrial and
cytosolic ROS are increased in YG8R cerebellar granule
neurons and result by the massive increase of lipid peroxida-
tion. Excessive ROS production results in oxidative stress and
reduces the level of GSH. We also proved that GSH is
decreased in granule cells, indicating that there is probably a
downregulation of the GSH antioxidant pathway, similar to
previous observations in other yeast and human lymphoblast
cell models.37,38 During oxidative stress, the most damaging
by-products are peroxidized lipids.28 Moreover, as conse-
quences of mitochondrial dysfunction and oxidative stress,
lipid peroxidation and its lipid-derived neurotoxins are con-
sidered to be one of the major causes of neurodegeneration,
since the CNS is especially enriched in polyunsaturated fatty
acids compared to other systems29,39 (Figure 8d).
We have recently described that this cascade of events
happens also in fibroblasts from YG8R and KIKO,40 another
validated FRDA models, and by using Nrf2-inducers we
rescued both the mitochondrial phenotype and prevented
the increase of lipid peroxidation.41 The activation of Nrf-2
pathway, indeed, not only triggers the increase of endogenous
GSH42 but also regenerates the substrates for Complexes I
Figure 5 Oxygen consumption in mitochondria from cerebellum. (a) The
histogram represent the rate of oxygen consumption originated from both Y47R and
YG8R, showing the basal and the maximal oxygen consumption of isolated
mitochondria from Y47R and YG8R cerebella, after administration of CI substrates
(5 mM glutamate and 5 mM malate). The maximal level is significantly decreased in
YG8R mitochondria (**Po0.005). (b) The histogram represents the respiratory
control calculated by state 3 divided to state 4, no significant differences were
witnessed. (c) The graph shows basal and the maximal oxygen consumption of
isolated mitochondria from Y47R and YG8R cerebella, after administration of the CII
substrate (5 mM succinate) and 10 μM rotenone (CI inhibitor) to exclude CI activity.
The maximal level shows a significant increase in YG8R compared with the control
(*Po0.05). (d) The histogram represents the respiratory control calculated by state 3
divided to state 4, showing no significant differences between the two genotypes
Figure 6 Mitochondrial complex activities in cerebellum of YG8R mice. (a) The
histogram shows the activity of CI measured from cerebellar homogenates, which
results decreased in YG8R mice (*P= 0.02). (b) Shows the activity of both CII–III
which is not significantly different between the two genotypes. (c) The histogram
shows the activity in CIV in Y47R and YG8R cerebellar homogenates. YG8R shows a
significant decrease of activity (**P= 0.008)
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and II of the mitochondrial respiratory chain.43 In FRDA
models, such as drosophila andmouse fibroblasts, it has been
found that the by-products of lipid peroxidation are massively
increased.41,44,45 By looking at lipid peroxidation, specifically
in granule cells, we found a dramatic increase in YG8R
compared to Y47R. Since lipid peroxidation is one of the most
toxic effects of oxidative stress in the CNS, we assessed
whether this could be a source of premature cell death in
YG8R granule cells. Cultures of granule cells were treated
with d4-PUFA, a compound known to prevent lipid
peroxidation.28,46,46 The reduction of lipid peroxidation
protected these granule cells, strongly implicating oxidative
stress as a major reason for degeneration in the mild form of
frataxin depletion.
In conclusion, we have studied cerebellar neuronal cells in
the YG8R FRDA mouse model, which presents with a slowly
progressive phenotype, similar to late-onset FRDA patients.
We assessed the type of mitochondrial dysfunction that was
present in the cerebellum, concluding that Complex I activity
is impaired, but Complex II compensates by overworking.
Therefore, if we consider the ETC, we can define the
mitochondrial dysfunction as a mildly defective bioenergetic
phenotype. However, this mild dysfunction drives the forma-
tion of free radicals that cannot be attenuated by the
endogenous antioxidant systems, which are downregulated.
Thus, the level of lipid peroxidation increases dramatically,
damaging the cells and causing premature cell death. We
have presented for the first time a full description of the
mitochondrial pathophysiological behaviour in the YG8R
mouse model and we have proven that the lipid peroxidation
is the major cause of cell toxicity in this model. Furthermore,
we have shown that by counteracting lipid peroxidation with
Figure 7 ROS increases and GSH decrease in cerebellar granule cells of FRDA-like cultures. (a and b) Mitochondrial ROS were measured with Mitosox in cerebellar granule
cells. The curves on the left show the increase over time of Mitosox fluorescence (a), which was quantified cell-by-cell as a rate of mROS generation (b). YG8R showed a
significant increase in rate of mROS generation (*Po0.05). (c and d) Similarly to the mROS also the cytosolic ROS were higher in the FRDA-like granule cells. Cytosolic were
measured with dihydroethidium (Het). The level of ROS production is visible with the Het kinetic over time (c) and the rate showed a significant increase of ROS (d; **Po0.005).
(e) By using monochlorobimane (MCB) we have measured the level of GSH in cerebellar granule neurons, which showed a significant difference between YG8R and control
(***P= 0.0001)
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d4-PUFA, in cerebellar granule cells, we can prevent neuronal
death. This was also confirmed recently on fibroblasts of
FRDA mouse models.41 Therefore, lipid peroxidation could be
a potential target for future therapeutic approaches in FRDA.
Materials and Methods
Cerebellar granule neuronal cultures. Primary cultures of cerebellar
granule neurons were obtained from cerebella of 6-day-old YG8R and Y47R
mice.13,14 Cerebella were triturated and then incubated with 0.25% Trypsin EDTA
solution (Sigma-Aldrich, Gillingham, UK) for 15 min at 37 °C. The homogenates
were centrifuged at 1000 r.p.m. for 4 min. Then, the tissues were washed with
HBSS w/o Ca2+ and Mg2+ and centrifuged twice before adding DMEM-glutamax at
10% fetal bovine serum, and penicillin and streptomycin. Cells were seeded on
glass coverslips and after 5 h Neurobasal A, B27, penicillin and streptomycin and L-
glutamine. The coverslips were pre-coated with Poly-D-lysine (1 mg/ml). Cells were
kept in Neurobasal A, glutamine, antibiotics and 25 mM KCL. Ara-C was added
within 24 h from the plating to prevent the over growth of non-neuronal cells.
Neurons were used after 9/10 days for all the experiments.47
Cerebellar slices. Cerebella were freshly isolated and placed immediately in
ice-cold HEPES-buffered salt solution (HBSS) composed (mM): 156 NaCl, 3 KCl,
2MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 glucose and 10 HEPES, pH 7.35 (HBSS 1 × )
and sliced at 1 °C using a vibratome (Leica VT1200S, Milton Keynes, UK).
Transverse acute cerebellar slices (~100 μm) were prepared from 8.5 months old
Y47R and YG8R mice. The tissue slices were cut and maintained in HBSS 1 × at
25 °C room temperature (RT) for ~ 1 h before imaging.
Immunofluorescence. Primary co-cultures of cerebellar granule neurons and
glia, plated on glass coverslips, were fixed with ice-cold 4% (v/v) paraformaldehyde
in phosphate-buffered saline (0.2 M Na2HPO4 adjusted with 0.2 M NaH2PO4 to pH
7.4) for 30 min and subsequently permeabilized for 15 min using 0.5% (v/v) Triton
X-100 in phosphate-buffered saline (PBS 1 × ). After a blocking step, with 3% BSA
and 10% goat serum dissolved in PBS 1 × and 0.1% Triton X-100, for 1 h at RT, the
cells were incubated with primary antibodies. Human frataxin was detected by using
a mouse monoclonal antibody (Abcam, Cambridge, UK) diluted 1:100. Neurons
were identified using chicken anti-MAP-2 (1:1000, Abcam). All the antibodies were
diluted in blocking solution and incubated overnight at 4 °C. Cells were washed with
PBS 1 × , and followed by 1 h incubation with the secondary antibody at RT. Anti-
mouse Alexafluor 565 (1:500) and anti-chicken Alexafluor 488 (1:500) in blocking
solution. 300 nM of DAPI was incubated for 5 min and washed with PBS 1 × .
Coverslips were mounted with Dako (Ely, Cambridgeshire, UK) mounting medium.
Western blotting. Isolated mitochondria from cerebella were resuspended in
ice-cold RIPA 1 × buffer (Sigma-Aldrich), with inhibitors of protease (Roche, West
Sussex, UK). After solubilisation, the samples were centrifuged at maximum speed
at 4 °C. BCA assay (Thermoscientific, Loughborough, UK) was applied to all the
samples. Loading buffer was added in a 1:1 ratio with the samples and boiled
samples at 100 °C for 10 min, and loaded onto a 10% acrylamide gel. The
electrophoresis was blotted to PVDF membrane. The blotting was done with mouse
α-hFXN (1:1000; Abcam) and rabbit α-AIF (1:1000; Abcam). Secondary HRP-
conjugated antibodies were used at a 1:5000 dilution. Analysis was done with Image
J software (Bethesda, MD, USA).
Mitochondrial membrane potential assay. Mitochondrial membrane
potential (ΔΨm) was measured with tetramethyl rhodamine methyl ester (TMRM,
25 nM, Invitrogen) in 'redistribution mode':48 the dye was allowed to equilibrate and
was present continuously in the recording solution. TMRM distributes between
cellular compartments in response to different potentials and, at concentrations
o50 nM, in healthy cells the fluorescent signal shows a mitochondrial localisation,
where is retained until mitotoxins induced depolarisation. The basal level of ΔΨm
was measured by exciting TMRM at 560 nm and collecting the images with a
590 nm long-pass filter. With Z-stacks configuration the fluorescence peaks from the
mitochondrial network were collected and analysed. The maintenance of ΔΨm was
measured after using 2 μg/ml oligomycin, 1 μM rotenone and 1 μM Fccp.
NADH autofluorescence. The autofluorescence of NADH and NADPH
(which can be referred to NAD(P)H) in cerebellar granule neurons cultures was
imaged on a Zeiss 510 META UV–vis confocal microscope (Cambridge, UK). The
blue autofluorescence emitted by the pyridine nucleotides NADH and NADPH in
their reduced form was excited with a UV laser (Coherent; at 351 nm; minimal laser
power) and emission was collected using a 435–485 nm band pass filter. To
Figure 8 Lipid peroxidation is increased in YG8R and anti-lipid peroxidation protects YG8R from cell death. (a) The graphs show respectively the kinetic ratio from Y47R and
YG8R, using C11-BODIPY and (b) shows the rate of lipid peroxidation in granule cells from Y47R and YG8R. The FRDA-like genotype results in a significant increase of lipid
peroxidation compared to control (**Po0.005). (c) The histogram shows the percentage of cell death in YG8R cerebellar granule cells, with and without 24 h treatment with
100 μM D4-PUFAs. This compound resulted to be protective showing a significant decrease in cell death (**Po0.005). (d) Summary of the results
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measure the dynamic range of the signal in relation to the full-mitochondrial NADH
pool and to normalise the data, the maximum oxidation and maximum reduction,
cells were exposed to carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP, 1 μM—to stimulate respiration and achieve maximum NADH oxidation) and
NaCN (1 mM—to inhibit respiration and achieve maximum NADH reduction). The
application of mitochondrial uncoupler 1 μM FCCP maximises the rate of respiration
and oxidises the mitochondrial NADH pool in cells, resulting in a decrease of
detected fluorescence (minimum= 0% for NADH; Figure 3a and b). The
subsequent application of the Complex IV inhibitor, 1 mM NaCN, suppresses
respiration preventing NADH oxidation and allowing the NADH pool to be
regenerated (maximum= 100% for NADH; Figure 3a and b).
The final formula used to normalise the NADH autofluorescence measurement
was: ΔF− Ffccp=ΔFNaCN− Ffccp.31 Quantitative analysis of the images obtained
was done using the Zeiss LSM 510 software.
FAD autofluorescence. The autofluorescence of FAD in cerebellar granule
neurons cultures was imaged on a Zeiss 710 confocal microscope. The green
autofluorescence emitted by the flavoproteins FAD in their oxidised form was excited
with an argon laser (Coherent; at 488 nm) and emission was collected after 510nm.
To measure the dynamic range of the signal in relation to the full-mitochondrial FAD
pool and to normalise the data, cells were exposed to FCCP, 1 μM—to stimulate
respiration and achieve maximum FAD oxidation, accompanied to an increased
fluorescence) and NaCN (1 mM—to inhibit respiration and achieve maximum FAD
reduction, accompanied to an decreased fluorescence).
The application of mitochondrial uncoupler 1 μM FCCP maximises the rate of
respiration and oxidises the mitochondrial FADH2 pool in cells, resulting in an
increase of detected fluorescence (maximum= 100% for FAD; Figure 4a). The
subsequent application of the Complex IV inhibitor, 1 mM NaCN, suppresses
respiration preventing FADH2 oxidation decreasing the fluorescence signal
(minimum= 0% for FAD; Figure 4a).
The formula used to normalise the FAD autofluorescence measurement was:
ΔF− FNaCN=ΔFfccp− FNaCN.31,43 Quantitative analysis of the images obtained was
done using the Zeiss Zen software.
Oxygen consumption in isolated mitochondria. To measure respira-
tion rate in isolated mitochondria from cerebella were extracted from fresh tissue
with isolation buffer (250 mM Sucrose, 5 mM Tris/HCl, 2 mM EGTA pH= 7.4/7.2
and 1% BSA). The cerebella were homogenised in a Teflon-glass homogeniser and
resuspended in the mitochondrial isolation buffer. The homogenates were
centrifuged at 6000 rpm at 4 °C for 11 min and then the supernatant was
transferred into a new tube and ultracentrifugated at 20 000 r.p.m. for 15 min at
4 °C. The pellet was then resuspended in 200 μl of isolation buffer and kept on ice
until the beginning of the experiments. The recording medium consisted of: 135 mM
KCl, 10 mM NaCl, 20 mM Hepes, 0.5 mM KH2PO4, 1 mM MgCl2, 5 mM EGTA,
1,86 mM CaCl2. A total of 5 mM pyruvate and 5 mM malate were added at the
beginning of the recording when complex I activity was assessed. 5 mM Succinate
and 10 μM Rotenone were added at the beginning of the experiment when complex
II activity was assessed. Experiments were conducted in a Clark-type oxygen
electrode thermostatically maintained at 25 °C. The oxygen electrode was calibrated
with air-saturated water, assuming 406 nmol Oatoms/ml at 25 °C (Oxytherm
system, Hansatech Instruments, Norfolk, UK). The rate of oxygen consumption was
measured using 50 nM ADP (state 3= V3), 2 μg/ml Oligomycin (state 4=V4) and
0.5 μM Fccp, which was added at the end of every experiment to establish maximal
uncoupled respiratory rate.
Complex activities. Cerebella were freshly isolated and immediately placed
in mitochondria isolation buffer: constitute of 320 mM sucrose, 1 mM EDTA and
10 mM Trizma-base. Samples were homogenised using a hand-held ground glass
homogeniser (Jencons Scientific Ltd, Bedfordshire, UK) using 1 g of tissue per 9 ml
of isolation buffer. Protein and mitochondrial enzymes were assayed spectro-
photometrically using a Uvikon XL spectrophotometer (Uvikon, Potton, UK).
Mitochondrial membranes were disrupted using three freeze-thaw cycles in liquid
nitrogen and a 30 °C water bath. Protein concentration was determined using the
method of Lowry using a Folin-Ciocalteu reagent (Bio-Rad Laboratories Ltd,
Hertfordshire, UK) containing a phosphomolybdic-tungstic mixed acid, to form a
blue chromogen detected with λmax of 750 nm. Complex I activity was determined
by monitoring the disappearance of NADH as it is oxidised to NAD+ with λmax of
340 nm and endogenous non-specific complex I activity subtracted after blocking
with rotenone. Complexes II–III activities were determined by monitoring the
succinate-dependent antimycin-A-sensitive reduction of cytochrome c with λmax of
550nm. Complex IV activity was determined by measuring the oxidation of reduced
cytochrome c by cytochrome oxidase with λmax of 550 nm. Citrate synthase activity
was determined using the49 assay. Enzyme activities are expressed as a ratio to CS
(mitochondrial marker enzyme) to compensate for mitochondrial enrichment in each
sample50 and total protein values.
Imaging ROS generation and lipid peroxidation. MitoSOX (10 μM)
was loaded for 10 min at RT, and then imaged with 488 nm laser and long-pass
530-nm emission filter, to assess mitochondrial ROS (mROS). To measure cytosolic
ROS generation of rates of ROS generation in the cytosol with dihydroethidium
(Het) (5 μM) the dye was present in all solutions throughout the experiments. No
preincubation was used to preserve the compound from early oxidation.51 Het was
excited at 530 nm and emissions were collected with a 560 nm long-pass filter,
using a Zeiss 710 CLSM confocal microscope. Lipid peroxidation was estimated by
using C11-BODIPY (5 mM; Molecular Probes, Loughborough, UK). Cells were
incubated with 10 μM C11-BODIPY (581/591) for 10 minutes and RT. C11-BODIPY
was excited using the 488 and 563 nm laser line, and fluorescence measured from
505 to 550 nm and 570 and 630 nm. Fluorescence was measured using a Zeiss
710 CLSM confocal microscope.
Glutathione measurements. To measure glutathione concentration (GSH),
cells were incubated with 50 μM monochlorobimane (MCB) in HBSS at room
temperature for 40 min, or until a steady state had been reached before images
were acquired for quantitation.52,53 The cells were then washed with HBSS, and
images of the fluorescence of the MCB-GSH adduct were acquired using a cooled
CCD imaging system as described using excitation at 380 nm and emission at
400 nm.
Cell death. Cells were treated 24 h with 100 μM d4-PUFA. Prior imaging, cells
were incubated with propidium iodide (PI; 10 μM) and 300 nM DAPI for 15 min,
washed 3x with PBS1x and analysed using a cooled CCD camera. DAPI stains all
nuclei while PI stains only cells with a disrupted plasma membrane. Dead cerebellar
granule neurons (PI positive), were counted as a fraction of the total. In each
experiment, 4200 neurons were examined in random fields from three
independent cultures for each condition.
Statistical analysis. Statistical analysis was performed with the aid of Origin 9
(Microcal Software Inc.) software. Results are expressed as means± S.E.M. The
ANOVA test was employed when appropriate and the point of minimum acceptable
statistical significance was taken to be 0.05, and was Bonferroni corrected where
required. Mann–Whitney U-test was used when independent experiments were
compared.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. PG and MAP have received funding from the European
Union Seventh Framework Programme (FP7/2007-2013) under grant agreement
number 242193/EFACTS, supporting RA and MHP (to PG) and CS (to MAP). PG has
received funding from FARA and GoFAR supporting RA. PG has received funding
from G&C Simeone Fund. We thank R. Molinari and M. Shchepinov (Retrotrope, Inc.)
for d4-PUFA compounds. PG received funding from BRC, NIHR of UCLH.
1. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of
early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981; 104:
589–620.
2. Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Clinical features of Friedreich's
ataxia: classical and atypical phenotypes. J Neurochem 2013; 126: 103–117.
3. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al.
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat
expansion. Science 1996; 271: 1423–1427.
4. Pandolfo M, Pastore A. The pathogenesis of Friedreich ataxia and the structure and function
of frataxin. J Neurol 2009; 256: 9–17.
5. Gomes CM, Santos R. Neurodegeneration in Friedreich's ataxia: from defective frataxin to
oxidative stress. Oxid Med Cell Longev 2013; 2013: 487534.
Energy imbalance and lipid peroxidation in FRDA
R Abeti et al
10
Cell Death and Disease
6. Dyck PJ, Gutrecht JA, Bastron JA, Karnes WE, Dale AJ. Histologic and teased-fiber
measurements of sural nerve in disorders of lower motor and primary sensory neurons.
Mayo Clin Proc 1968; 43: 81–123.
7. Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S et al. The dentate nucleus in
Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol 2007; 114:
163–173.
8. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J et al. Mouse models for
Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency
followed by intramitochondrial iron deposits. Nat Genet 2001; 27: 181–186.
9. Al-Mahdawi S, Pinto RM, Ruddle P, Carroll C, Webster Z, Pook M. GAA repeat instability in
Friedreich ataxia YAC transgenic mice. Genomics 2004; 84: 301–310.
10. Clark RM, De B I, Malykhina AP, Al-Mahdawi S, Pook M, Bidichandani SI. The GAA triplet-
repeat is unstable in the context of the human FXN locus and displays age-dependent
expansions in cerebellum and DRG in a transgenic mouse model. Hum Genet 2007; 120:
633–640.
11. De BI, Rasmussen A, Endres D, Al-Mahdawi S, Monticelli A, Cocozza S et al. Progressive
GAA expansions in dorsal root ganglia of Friedreich's ataxia patients. Ann Neurol 2007; 61:
55–60.
12. De BI, Rasmussen A, Monticelli A, Al-Mahdawi S, Pook M, Cocozza S et al. Somatic
instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses
throughout life. Genomics 2007; 90: 1–5.
13. Pook MA, Al-Mahdawi S, Carroll CJ, Cossee M, Puccio H, Lawrence L et al. Rescue of the
Friedreich's ataxia knockout mouse by human YAC transgenesis. Neurogenetics 2001; 3:
185–193.
14. Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S et al. GAA repeat
expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to
progressive neuronal and cardiac pathology. Genomics 2006; 88: 580–590.
15. Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, Sandi C et al. The
Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic
changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 2008; 17:
735–746.
16. Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich's ataxia. Acta
Neuropathol 2011; 122: 323–330.
17. Koeppen AH, Morral JA, McComb RD, Feustel PJ. The neuropathology of late-onset
Friedreich's ataxia. Cerebellum 2011; 10: 96–103.
18. Morral JA, Davis AN, Qian J, Gelman BB, Koeppen AH. Pathology and pathogenesis of
sensory neuropathy in Friedreich's ataxia. Acta Neuropathol 2010; 120: 97–108.
19. Simon D, Seznec H, Gansmuller A, Carelle N, Weber P, Metzger D et al. Friedreich ataxia
mouse models with progressive cerebellar and sensory ataxia reveal autophagic
neurodegeneration in dorsal root ganglia. J Neurosci 2004; 24: 1987–1995.
20. Cavadini P, O'Neill HA, Benada O, Isaya G. Assembly and iron-binding properties
of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet 2002; 11:
217–227.
21. Martelli A, Wattenhofer-Donze M, Schmucker S, Bouvet S, Reutenauer L, Puccio H. Frataxin
is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum Mol
Genet 2007; 16: 2651–2658.
22. Rotig A, de LP, Chretien D, Foury F, Koenig M, Sidi D et al. Aconitase and mitochondrial iron-
sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997; 17: 215–217.
23. Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY et al.
Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1.
Cell Metab 2008; 8: 13–25.
24. Peuchen S, Duchen MR, Clark JB. Energy metabolism of adult astrocytes in vitro.
Neuroscience 1996; 71: 855–870.
25. Lee S, Tak E, Lee J, Rashid MA, Murphy MP, Ha J et al.Mitochondrial H2O2 generated from
electron transport chain complex I stimulates muscle differentiation. Cell Res 2011; 21:
817–834.
26. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417:
1–13.
27. Abramov AY, Smulders-Srinivasan TK, Kirby DM, Acin-Perez R, Enriquez JA, Lightowlers RN
et al. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain
2010; 133: 797–807.
28. Hill S, Lamberson CR, Xu L, To R, Tsui HS, Shmanai VV et al. Small amounts of isotope-
reinforced polyunsaturated fatty acids suppress lipid autoxidation. Free Radic Biol Med 2012;
53: 893–906.
29. Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS. Lipid
peroxidation is essential for alpha-synuclein-induced cell death. J Neurochem 2015; 133:
582–589.
30. Dobretsov GE, Petrov VA, Borshchevskaia TA, Deev AI, Vladimirov I. Effect of peroxidation
on the physical structure of phospholipid membranes. Vopr Med Khim 1977; 6: 818–822.
31. Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic
metabolic failure and neuronal death. Brain 2011; 134: 1658–1672.
32. Kauppinen TM, Gan L, Swanson RA. Poly(ADP-ribose) polymerase-1-induced NAD(+)
depletion promotes nuclear factor-kappaB transcriptional activity by preventing p65 de-
acetylation. Biochim Biophys Acta 2013; 1833: 1985–1991.
33. Wagner GR, Pride PM, Babbey CM, Payne RM. Friedreich's ataxia reveals a mechanism
for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3
deacetylase. Hum Mol Genet 2012; 21: 2688–2697.
34. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu
Rev Pathol 2010; 5: 253–295.
35. Napoli E, Taroni F, Cortopassi GA. Frataxin, iron-sulfur clusters, heme, ROS, and aging.
Antioxid Redox Signal 2006; 8: 506–516.
36. Xu X, Arriaga EA. Qualitative determination of superoxide release at both sides of the
mitochondrial inner membrane by capillary electrophoretic analysis of the oxidation products
of triphenylphosphonium hydroethidine. Free Radic Biol Med 2009; 46: 905–913.
37. Auchere F, Santos R, Planamente S, Lesuisse E, Camadro JM. Glutathione-dependent
redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia. Hum Mol Genet
2008; 17: 2790–2802.
38. Bulteau AL, Planamente S, Jornea L, Dur A, Lesuisse E, Camadro JM et al. Changes in
mitochondrial glutathione levels and protein thiol oxidation in yfh1 yeast cells and the
lymphoblasts of patients with Friedreich's ataxia. Biochim Biophys Acta 2012; 1822: 212–225.
39. Picklo MJ Sr., Montine TJ. Mitochondrial effects of lipid-derived neurotoxins. J Alzheimers
Dis 2007; 12: 185–193.
40. Miranda CJ, Santos MM, Ohshima K, Smith J, Li L, Bunting M et al. Frataxin knockin mouse.
FEBS Lett 2002; 512: 291–297.
41. Abeti R, Uzun E, Renganathan I, Honda T, Pook MA, Giunti P. Targeting lipid peroxidation
and mitochondrial imbalance in Friedreich's ataxia. Pharmacol Res 2015; 99: 344–350.
42. Greco T, Shafer J, Fiskum G. Sulforaphane inhibits mitochondrial permeability transition and
oxidative stress. Free Radic Biol Med 2011; 51: 2164–2171.
43. Holmstrom KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM et al. Nrf2 impacts
cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol
Open 2013; 2: 761–770.
44. Bradley JL, Homayoun S, Hart PE, Schapira AH, Cooper JM. Role of oxidative damage in
Friedreich's ataxia. Neurochem Res 2004; 29: 561–567.
45. Navarro JA, Ohmann E, Sanchez D, Botella JA, Liebisch G, Molto MD et al. Altered lipid
metabolism in a Drosophila model of Friedreich's ataxia. Hum Mol Genet 2010; 19:
2828–2840.
46. Hill S, Hirano K, Shmanai VV, Marbois BN, Vidovic D, Bekish AV et al. Isotope-reinforced
polyunsaturated fatty acids protect yeast cells from oxidative stress. Free Radic Biol Med
2011; 50: 130–138.
47. Scorziello A, Meucci O, Florio T, Fattore M, Forloni G, Salmona M et al. Beta 25-35 alters
calcium homeostasis and induces neurotoxicity in cerebellar granule cells. J Neurochem
1996; 66: 1995–2003.
48. Duchen MR, Surin A, Jacobson J. Imaging mitochondrial function in intact cells. Methods
Enzymol 2003; 361: 353–389.
49. Shepherd D, Garland PB. The kinetic properties of citrate synthase from rat liver
mitochondria. Biochem J 1969; 114: 597–610.
50. Duberley KE, Abramov AY, Chalasani A, Heales SJ, Rahman S, Hargreaves IP. Human
neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain
activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity:
implications for pathogenesis and treatment. J Inherit Metab Dis 2013; 36: 63–73.
51. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free
radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci
2007; 27: 1129–1138.
52. Keelan J, Allen NJ, Antcliffe D, Pal S, Duchen MR. Quantitative imaging of glutathione in
hippocampal neurons and glia in culture using monochlorobimane. J Neurosci Res 2001; 66:
873–884.
53. Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial
dysfunction and oxidative stress in astrocytes and death of neurons through activation of
NADPH oxidase. J Neurosci 2004; 24: 565–575.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from
the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
Energy imbalance and lipid peroxidation in FRDA
R Abeti et al
11
Cell Death and Disease
